RxDoctor Payments DataLook up a doctor →

TACROLIMUS: payments to doctors

Payments that named TACROLIMUS as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$81K
Providers
27
Transactions
57
Average per transaction
$1,418

The per-transaction average — $1,418 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 27 providers the average total is $2,993, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Astellas Pharma Inc$77,97596.5%
Astellas Pharma Global Development$2,4803.1%
Astellas Pharma US Inc$3540.4%
← All drugs & devices